Hubei Mon Yan Pharmaceutical

Hubei Mengyang Pharmaceutical is a specialized pharmaceutical enterprise based in Jingmen, China, focusing on the modernization of Traditional Chinese Medicine (TCM). The company integrates research, development, production, and sales, with a core focus on oncology-supportive care and hematology. Its flagship product, Shengxue Xiaoban Granules, is a recognized treatment for chemotherapy-induced thrombocytopenia and other blood-related disorders. Beyond hematology, the company produces a range of therapies for cardiovascular, respiratory, and digestive ailments. Mengyang Pharmaceutical operates under strict GMP standards and has been recognized as a High-Tech Enterprise in Hubei Province.